Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function

The Prostate
A Zolfaghari, D Djakiew

Abstract

Chemoattractants expressed at bony sites and pelvic lymph nodes are thought to promote the preferential metastasis of human prostate tumor cells to these organs. Epidermal growth factor (EGF) is a potent chemoattractant for several human metastatic prostate tumor cell lines, including the TSU-pr1 cell line, and EGF has been localized to the stroma of both bony sites and pelvic lymph nodes in humans. Hence, we investigated whether the TSU-pr1 cell line expresses a functional EGF receptor (EGFR), which when antagonized reduces EGF-mediated chemomigration of this cell line. In this context, the EGFR immunoprecipitated from cell lysates of TSU-pr1 cells comigrated with the EGFR from A431 cells at a molecular weight of 170 kD. Addition of human EGF (hEGF) to the TSU-pr1 cells for 5 min stimulated the dose-dependent biphasic phosphorylation of the EGFR, with maximal stimulation of EGFR phosphorylation occurring at 2 ng/ml hEGF. In addition, treatment of hEGF-stimulated (2 ng/ml) TSU-pr1 cells with 0.5 microgram/ml anti-hEGF monoclonal antibody or 100 nM staurosporine inhibited EGFR phosphorylation. Conversely, as negative controls, treatment of hEGF-stimulated (2 ng/ml) TSU-pr1 cells with K252a or dimethyl sulfoxide (DMSO) vehicle di...Continue Reading

References

Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P MignattiD B Rifkin
Aug 15, 1990·International Journal of Cancer. Journal International Du Cancer·E C KohnE Schiffmann
May 1, 1988·The Journal of Urology·S C JacobsR K Lawson
Sep 1, 1988·Clinical & Experimental Metastasis·D H ShevrinT E Lad
Jan 1, 1993·Breast Cancer Research and Treatment·F W OrrG Singh

❮ Previous
Next ❯

Citations

Jan 27, 1997·The Journal of Cell Biology·E DicouD Harvie
Oct 28, 2014·Expert Opinion on Emerging Drugs·Michelle A OjemuyiwaWilliam L Dahut
Feb 22, 2002·BJU International·G O Hellawell, S F Brewster
Feb 22, 2002·International Journal of Cancer. Journal International Du Cancer·Scott Krygier, Daniel Djakiew
Oct 21, 2004·Cancer·David G BostwickBarry Timms
Feb 8, 2002·The Journal of Urology·Ganesh V RajYehia Daaka
Nov 1, 2000·The Journal of Biological Chemistry·K J ReidC C Nelson
Feb 27, 1999·Endocrine Reviews·E RuijterJ Schalken
Jun 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ana L TeixeiraRui Medeiros
Sep 16, 1999·Experimental Neurology·J S YakisichM Cruz
Dec 8, 2006·Surgical Oncology·Manit AryaHiten R Patel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.